Quick Takeaways
- Samsara BioCapital, L.P. filed SCHEDULE 13D/A for KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KLRS).
- Disclosed ownership: 56%.
- Date of event: 22 Dec 2025.
Quoteable Key Fact
"Samsara BioCapital, L.P. disclosed 56% ownership in KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KLRS) on 22 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. | 50% | 11,448,081 | 0 | 11,448,081 | /s/ Srinivas Akkaraju | By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member | 0001699737 |
| Samsara BioCapital GP, LLC | 50% | 11,448,081 | 0 | 11,448,081 | /s/ Srinivas Akkaraju | By Srinivas Akkaraju, Managing Member | 0001888829 |
| Samsara Opportunity Fund, L.P. | 6.5% | 1,500,000 | 0 | 1,500,000 | /s/ Srinivas Akkaraju | By Samsara Opportunity Fund GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member | 0002086193 |
| Samsara Opportunity Fund GP, LLC | 6.5% | 1,500,000 | 0 | 1,500,000 | /s/ Srinivas Akkaraju | By Srinivas Akkaraju, Managing Member | 0002086456 |
| Srinivas Akkaraju | 56% | 12,953,581 | 5,500 | 12,948,081 | /s/ Srinivas Akkaraju | Srinivas Akkaraju | 0001253170 |